Tripos Awarded NIH Grant to Develop Screening and Optimization Technology for Drug Discovery
Based on topomer technology, this proprietary system will have the capacity to search a million times more structures than previously possible, providing a richer universe of synthetic chemistries. Scientists will be able to extend their knowledge of similar molecules, resulting in improved success rates for all stages of drug discovery. This system also has the potential to be licensed to other drug discovery research operations under the appropriate technology transfer agreements.
"The award of this grant opens up the next phase of a 10-year, in-house research effort," said Dr. Richard D. Cramer, senior vice president of science and chief science officer for Tripos. "The most important advantages offered by topomers are efficacy and speed, two critical considerations in drug discovery research. Tripos has incorporated this technology into its lead optimization collaborations and is able to offer its partners better success rates and an improved cost-to-benefit ratio as a result."
Most read news
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.